Intravenous Immunoglobulin (IVIG)
Orphan Drug Cold Chain RequiredFDA Approved
Description
IVIG is a blood product containing pooled IgG antibodies extracted from the plasma of many blood donors. It is used to treat a variety of immunodeficiency and autoimmune diseases.
Indications & Therapeutic Use
Syndromic agammaglobulinemia
Linked Diseases:
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Intravenous Immunoglobulin (IVIG)
| Generic Name | Intravenous Immunoglobulin (IVIG) |
| Drug Class | Syndromic agammaglobulinemia |
| Dosage Forms | IV Infusion |
| Medical Code | J06BA |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Reg. Status | FDA Approved |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes